Clinical Trial

Minimal Vitrectomy Surgery for Epiretinal Membrane

Study acronym: MVS-ERM
Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter randomized controlled trial evaluates Minimal Vitrectomy Surgery (MVS) versus conventional vitrectomy for idiopathic epiretinal membrane (ERM). The primary endpoints include visual acuity improvement and cataract progression after 12 months. MVS aims to minimize vitreous removal while ensuring complete membrane removal through adaptive limited vitrectomy.
Trial Details
NCT Number NCT07019896
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Peking Union Medical College
Conditions Epiretinal Membrane, Macular Edema (ME), Nuclear Cataract
Enrollment 140 participants
Start Date 2024-12-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-13